These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38659389)

  • 1. Inappropriate Peak Inspiratory Flow Rate in the Patients with Stable Chronic Obstructive Pulmonary Disease in Korea.
    Youn SH; Kim HJ; Park JS; Park SH; Kwon YS; Kim MA
    Tuberc Respir Dis (Seoul); 2024 Oct; 87(4):458-464. PubMed ID: 38659389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suboptimal peak inspiratory flow rate in dry-powder inhaler users for chronic obstructive pulmonary disease in Korea.
    Moon JY; Kim SH; Kim Y; Lee H; Rhee CK; Ra SW; Lee CY; Park JH; Park YB; Yoo KH
    Pulm Pharmacol Ther; 2024 Jun; 85():102298. PubMed ID: 38604404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and predictors of suboptimal peak inspiratory flow rate in COPD patients.
    Harb HS; Laz NI; Rabea H; Abdelrahim MEA
    Eur J Pharm Sci; 2020 Apr; 147():105298. PubMed ID: 32151707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD.
    Ghosh S; Pleasants RA; Ohar JA; Donohue JF; Drummond MB
    Int J Chron Obstruct Pulmon Dis; 2019; 14():585-595. PubMed ID: 30880948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peak inspiratory flow rate measurement by using In-Check DIAL for the different inhaler devices in elderly with obstructive airway diseases.
    Kawamatawong T; Khiawwan S; Pornsuriyasak P
    J Asthma Allergy; 2017; 10():17-21. PubMed ID: 28260934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Preliminary Bronchodilator Dose in Chronic Obstructive Pulmonary Disease Patients With Suboptimal Peak Inspiratory Flow.
    Hassan MI; Laz NI; Madney YM; Abdelrahim MEA; Harb HS
    Clin Ther; 2024 Dec; 46(12):e16-e24. PubMed ID: 39353752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of Suboptimal Peak Inspiratory Flow Rates among Patients with Chronic Obstructive Pulmonary Disease in Southwest, Nigeria.
    Arawomo AO; Erhabor GE; Tanimowo MO; Awopeju OF; Adewole OO; Adeniyi BO; Afolabi BA; Ekundayo MW
    West Afr J Med; 2023 May; 40(5):553-561. PubMed ID: 37247343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing inhalation therapy in the aspect of peak inhalation flow rate in patients with chronic obstructive pulmonary disease or asthma.
    Hua JL; Ye XF; Du CL; Xie N; Zhang JQ; Li M; Zhang J
    BMC Pulm Med; 2021 Sep; 21(1):302. PubMed ID: 34560863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spirometry Measurement of Peak Inspiratory Flow Identifies Suboptimal Use of Dry Powder Inhalers in Ambulatory Patients with COPD.
    Duarte AG; Tung L; Zhang W; Hsu ES; Kuo YF; Sharma G
    Chronic Obstr Pulm Dis; 2019 Jul; 6(3):246-255. PubMed ID: 31189057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers.
    Ghosh S; Ohar JA; Drummond MB
    J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):381-387. PubMed ID: 28933581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suboptimal peak inspiratory flow rate: a noticeable risk factor for inhaler concordance in patients with chronic airway diseases.
    Meng W; Xiong R; Zhao Z; Zeng H; Chen Y
    BMJ Open Respir Res; 2024 Apr; 11(1):. PubMed ID: 38642917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Factors Affecting the Optimal and Non-optimal Peak Inspiratory Flow Rate in Stable and Exacerbation Phases of Chronic Obstructive Pulmonary Disease and Bronchial Asthma in India.
    Murugaiya S; Murugesan B; S P
    Cureus; 2024 Apr; 16(4):e58670. PubMed ID: 38774171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of chronic obstructive pulmonary disease patients with superoptimal peak inspiratory flow rate.
    Kim T; Moon JY; Park HY; Kim Y; Rhee CK; Lee CY; Park JH; Park YB; Russell R; Yoo KH; Ra SW
    Sci Rep; 2024 Jul; 14(1):15337. PubMed ID: 38961087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between Hand Grip Strength and Peak Inspiratory Flow Rate in Patients with Stable Chronic Obstructive Pulmonary Disease.
    Suriyakul A; Saiphoklang N; Barjaktarevic I; Cooper CB
    Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
    Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1055-1067. PubMed ID: 37914418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can patients achieve sufficient peak inspiratory flow rate (PIFR) with Turbuhaler® during acute exacerbation of asthma?
    Mohd Rhazi NA; Muneswarao J; Abdul Aziz F; Ibrahim B; Kamalludin A; Soelar SA
    J Asthma; 2023 Aug; 60(8):1608-1612. PubMed ID: 36650693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and COPD phenotype for a suboptimal peak inspiratory flow rate against the simulated resistance of the Diskus® dry powder inhaler.
    Mahler DA; Waterman LA; Gifford AH
    J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):174-9. PubMed ID: 23025451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the relationship between peak inspiratory flow rate and volume of inhalation from a Diskus™ Inhaler and baseline spirometric parameters: a cross-sectional study.
    Seheult JN; Costello S; Tee KC; Bholah T; Al Bannai H; Sulaiman I; Costello RW
    Springerplus; 2014; 3():496. PubMed ID: 25279290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Low Peak Inspiratory Flow Rate at Discharge in Patients Hospitalized for COPD Exacerbation.
    Sharma G; Mahler DA; Mayorga VM; Deering KL; Harshaw O; Ganapathy V
    Chronic Obstr Pulm Dis; 2017 Jul; 4(3):217-224. PubMed ID: 28848933
    [No Abstract]   [Full Text] [Related]  

  • 20. Aerosol drug-delivery and short-term clinical outcomes of suboptimal peak inspiratory flow rate in chronic obstructive pulmonary disease.
    Harb HS; Ibrahim Laz N; Rabea H; Madney YM; Boshra MS; Abdelrahim MEA
    Int J Clin Pract; 2021 Dec; 75(12):e14845. PubMed ID: 34519141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.